Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipragliflozin in T2DM with Renal Impairment
NCT01316094Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ipragliflozin in type 2 diabetes mellitus (T2DM), sponsored by Astellas Pharma. Started Jan 2011; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01316094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316094.